Exabis Library
Welcome to the e-CCO Library!
P467: Perception Gap between Patients with Inflammatory Bowel Disease (IBD) and Physicians in China: A Cross-sectional Study
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P467: The validation of the Crohn’s and Ulcerative Colitis Questionnaire–12 Plus (CUCQ-12 plus): a short quality-of-life measure for inflammatory bowel disease
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P467: Therapeutic drug monitoring of biologics in Inflammatory Bowel Disease: Nordic survey on implementation and barriers in clinical practice
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P468 Switching from adalimumab originator to ABP 501 biosimilar: a multicentre North Italian study
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P468: Analysis of international spontaneous reporting system databases for safety of corticosteroids in Inflammatory Bowel Disease: The Determinants, Incidence and consequences of Corticosteroid Excess (DICE)-impact study
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P468: Association of uncontrolled disease with quality of life and healthcare resource utilisation in Ulcerative Colitis patients treated with advanced therapy in the United States
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P468: Etrolizumab treatment improves histological activity as assessed by the Robarts histopathology index
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P468: Evaluation of work productivity and activity impairment in moderate-to-severe ulcerative colitis participants treated with ozanimod in the phase 3 True North study
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P468: Long-term efficacy and safety of thiopurine in biologic-naïve Japanese patients with ulcerative colitis: a multicentre retrospective study
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P468: Long-term function after transanal vs. transabdominal ileal pouch-anal anastomosis for ulcerative colitis: a multi-centre cohort study
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P468: Microscopic colitis: systematic analysis of 200 adult patients with a mean follow-up of 4 years
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P469 Stay in class or switch out of class after anti-TNF failure in inflammatory bowel disease (IBD). Real-world data from a large district general hospital
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P469: Changes in peripheral blood lymphocyte subsets induced by azathioprine in Crohn’s disease patients
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P469: Effect of mirikizumab on clinical and endoscopic outcomes based on prior advanced therapy failure in patients with moderately to severely active ulcerative colitis
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P469: Effectiveness of dose optimisation by pre-genotyping NUDT 15 R139C on reducing thiopurine-induced leucopoenia in Chinese patients with Crohn’s disease: a randomised controlled trial
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P469: Infliximab for induction of medically-induced remission in Crohn's disease: a Cochrane systematic review
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P469: Safety, tolerability, and pharmacokinetics of the intestine-restricted oral pan-Janus kinase inhibitor TD-1473 after single and multiple oral doses in healthy subjects
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P469: Self-reported cutaneous side effects of anti-TNF therapy in inflammatory bowel disease patients
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P469: The PROPER study: interim analysis of a pan-European real-world study of SB5 adalimumab biosimilar after transition from reference adalimumab in patients with Crohn’s disease
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P470 The concept of illness identity in inflammatory bowel disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM